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The activities, properties, and steady-state kinetics of the five enzymes catalyzing the 
synthesis of 1-acyl- and 1-alkyl-an-glycerol3-phosphate in the cultured skin fibroblasts 
from Zellweger syndrome patients and normal controls were studied in detail. Judging 
from their Km and V,,, values, glycerol phosphate acyltransferase (EC 2.3.1.15), acyl/ 
alkyl dihydroxyacetone phosphate reductase (EC l.l.l.lOl), and acyl coenzyme A re- 
ductase (long-chain alcohol forming), appear to be affected only slightly by the absence 
of peroxisomes characteristic of the Zellweger syndrome. Glycerophosphate acyltrans- 
ferase also showed no differences in N-ethylmaleimide sensitivity nor in inhibition by 
dihydroxyacetone phosphate between these cell types. Dihydroxyacetone phosphate 
acyltransferase (EC 2.3.1.42) and alkyl dihydroxyacetone phosphate synthase (EC 
2.5.1.26) have altered activity and kinetic constants in homogenates from Zellweger 
syndrome fibroblasts. Dihydroxyacetone phosphate acyltransferase has similar Km 
(DHAP) values in both control and Zellweger syndrome cells; however, the value for 
the K,, in Zellweger syndrome cells is only 6% of that found in the controls. This is 
interpreted as indicating that this enzyme is not defective in this disease but is simply 
present at a depressed level. Also, this enzyme activity has a maximum rate at pH 7.0- 
7.5 in the mutant cells as opposed to pH 5.4 in the controls. Acylation of dihydroxyacetone 
phosphate by control cell homogenate was stimulated by N-ethylmaleimide at both pH 
5.7 and 7.5 whereas this activity from Zellweger syndrome cells was slightly inhibited 
at pH 5.7 and strongly inhibited at pH 7.5. In the absence of detergent, dihydroxyacetone 
phosphate acyltransferase in the Zellweger syndrome cells was much more labile to 
trypsin than in the control cells. Alkyl dihydroxyacetone phosphate synthase had a 
slightly higher K,(33 vs 17 PM) for palmitoyl dihydroxyacetone phosphate and a lower 
V,,, (0.07 vs 0.24 mU/mg protein) in the Zellweger syndrome cells as compared to 
controls. Although this is a substantial decrease in activity, it probably contributes 
little to the decreased rate of ether lipid synthesis in these cells. The major problem in 
this respect is apparently the loss of dihydroxyacetone phosphate acyltransferase ac- 
tivity. All of these enzymes, in both control and Zellweger syndrome cell homogenates, 
are sedimentable by centrifugation at 100,000~. Also, with the exception of dihydroxy- 
acetone phosphate acyltransferase they had similar patterns of inactivation by heat in 
both cell types. 0 1987 Academic Press, Inc 
Zellweger syndrome (ZS)’ is a rare, au- births (1). Children with this disease are 
tosomal-recessive disorder estimated to born with a characteristic facial morphol- 
occur in more than one out of 100,000 live ogy and soon develop hypotonia and severe 
neurological dysfunction (2). The progres- 
r To whom correspondence should be addressed. 
sive loss of liver and kidney function usu- 
a Abbreviations used: DHAP, dihydroxyacetone ally results in death within the first post- 
phosphate; GP, sn-glycerol 3-phosphate; AT, acyl- natal year. Among the associated bio- 
transferase; Mes, 4-morpholone-ethane-sulfonic acid; chemical abnormalities that have been 
ZS, Zellweger syndrome; NEM, N-ethylmaleimide; reported are deficiencies in mitochondrial 
mu, nmol/min. electron transport (3), pipecolic acid me- 
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tabolism (4), bile acid synthesis (5), oxi- 
dation of very-long-chain fatty acids (6), 
and ether lipid biosynthesis (7-9). Clearly 
the physiological consequences of this dis- 
ease are extensive. The present work is di- 
rected specifically at the aspect of lipid 
biosynthesis. 
The tissues of patients with this disease 
are virtually devoid of peroxisomes (3). 
This fact and the discovery by Hajra et al. 
(10, 11) that DHAP acyltransferase (the 
first enzyme in the pathway of glycerol 
ether lipid biosynthesis) is localized in liver 
peroxisomes led Borst to postulate that ZS 
patients would have a severe deficiency of 
plasmalogen (12). This was shown to be the 
case by Heymans et aL (13). Subsequently 
Lazarow et aZ. (9), Datta et al. (14), and 
Schutgens et al. (8) demonstrated that tis- 
sues from these patients were deficient in 
DHAP acyltransferase activity. Further 
work from our laboratory (7), with cultured 
skin fibroblasts, extended the biochemical 
study of this disease to include two other 
enzymes of the acyl DHAP pathway (acyl/ 
alkyl DHAP reductase and alkyl DHAP 
synthase) as well as GP acyltransferase. 
The present study provides more detailed 
information concerning the properties and 
steady-state kinetic parameters of these 
acyl DHAP pathway enzymes as well as 
GP acyltransferase and acyl CoA reductase 
in normal and ZS fibroblasts. 
MATERIALS 
Palmitoyl coenzyme A, trypsin, trypsin inhibitor, 
NazEDTA, and hexadecanol were obtained from 
Sigma Chemical Co. (St. Louis, MO). Eagle’s minimum 
essential medium (powdered) and fetal calf serum 
were purchased from GIBCO. 
[azP]DHAP and $P]GP were prepared by the en- 
zymatic phosphorylation of dihydroxyacetone and 
glycerol, respectively, with [y-“P]ATP, as described 
previously (15). [l-*4C]Palmitoyl CoA was chemically 
prepared from [1-“Clpalmitic acid and CoASH as de- 
scribed by Bishop and Hajra (16). Acyl and alkyl 
DHAP were chemically synthesized as described by 
Hajra et al. (1’7). 
Other compounds were of reagent grade or better. 
METHODS 
Zellweger syndrome fibroblast cell lines GM 0228 
and GM 4340 were obtained from the Human Mutant 
Cell Repository of the National Institute of General 
Medical Sciences. Cells were cultured in Eagle’s min- 
imum essential media (GIBCO) supplemented with 
20% fetal calf serum (GIBCO). Cultures were split 1: 
4 at weekly intervals and the medium was changed 
once between each split. The cells were harvested by 
first rinsing them with 0.05% trypsin in isotonic saline 
containing 5 rnrd EDTA and then releasing them from 
the surface with 0.2% trypsin in saline/EDTA. An 
equal volume of 0.2% trypsin inhibitor (soybean, 
Sigma) in saline was added immediately to stop the 
proteolytic action. The cells were pelleted at 200s for 
8 min followed by three washes with isotonic saline/ 
5 mM EDTA. The final pellet was stored at -70°C 
until assay. Prior to assay the cells were ruptured by 
sonication (3 X 15 s) at O’C in 0.25 M sucrose-l mM 
EDTA with a miniprobe sonicator (Kontes Inst.). The 
homogenate was centrifuged at 1OOOg for 10 min to 
pellet unbroken cells. The supernatant was used for 
assays. 
DHAP acyltransferase and GP acyltransferase were 
assayed by measuring the amount of labeled lipid 
formed from the q-labeled DHAP or GP and pal- 
mitoyl coenzyme A as described previously (10, 15) 
except that substrates with high specific radioactivity 
(2 X lO’cpm/nmol) were used for a higher sensitivity. 
The assay mixture contained ‘75 rnrd Tris-Cl (pH 7.5) 
or Mes (pH 5.7), 83 pM palmitoyl CoA, 8.3 mM NaF, 
8.3 mM MgClz, 0.42 mM DHAP or GP, plus bovine 
serum albumin (1.67 mg/ml for DHAP acyltransferase 
or 2.5 mg/ml for GP acyltransferase) in a total volume 
of 0.6 ml including cell homogenate. After a 15min 
incubation at 37°C lipids were extracted by an acidic 
Bligh and Dyer method (18) and dried and radioactive 
products were determined by liquid scintillation 
counting. Acyl/alkyl DHAP reductase was assayed 
by measuring the amount of radioactive lipid formed 
from B-[4-‘HiNADPH and 1-0-hexadecyl DHAP (19). 
Alkyl DHAP synthase was assayed by measuring the 
amount of alkali-stable lipid formed from palmitoyl 
[=P]DHAP and hexadecanol(20) or the amount of ra- 
dioactive polar product formed from [1-“Cl- 
hexadecanol and palmitoyl DHAP (20). Acyl coenzyme 
A reductase was assayed by measuring the amount 
of radioactive hexadecanol formed from [1-‘4C]- 
palmitoyl coenzyme A and NADPH by a modifi- 
cation of the procedure of Bishop and Hajra (21). The 
assay mixture contained 12.3 pM [1-i4C]palmitoyl CoA 
(123,000 cpm/nmol), 1.2 mg/ml bovine serum albumin, 
10 mM MgClz, 1 mM glucose B-phosphate, 57.5 mu glu- 
cose-6-phosphate dehydrogenase, and NADPH (usu- 
ally 60 pM) plus fibroblast homogenate in a total vol- 
ume of 0.5 ml. After incubation at 37°C for 40 min, 
lipids were extracted and washed according to Bligh 
and Dyer (22). The lipids were separated by TLC with 
CHQ-CH*OH-7.3 M NH,OH (92/2/O& v/v). Radio- 
active hexadecanol was located by autoradiography 
(Rf = 0.45), scraped out, and counted in a Iipid scin- 
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tillation counter. Protein content of samples was as- 
sayed by the method of Lowry et al. (23) with bovine 
serum albumin as the standard. 
RESULTS 
The relative rates of acylation of DHAP 
and GP by homogenates of ZS and control 
cells at various pH values is shown in Fig. 
1. In the control cells, the maximum rates 
of acylation of DHAP and GP occur at pH 
5.4 and 7.0, respectively. In the ZS cells, the 
effect of pH on GP acylation is normal; 
however, acylation of DHAP shows a max- 
imum at pH 7-7.5 with another peak at pH 
5.5. The relative activity of DHAP acyl- 
transferase in ZS cells is 2% at pH 5.4 and 
12% at pH 7.0 of the control values 
(Fig. 1). 
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FIG. 1. Effect of assay pH on the rate of acyl DHAP 
formation by homogenates of control and ZS fibro- 
blasts. Assay conditions are given in text. 0 = control; 
0 = ZS. Maximum activities for DHAP acyltransfer- 
ase are 0.71 and 0.04 mU/mg protein for control and 
ZS, respectively. Maximum activities for GP acyl- 
transferase are 0.73 and 1.00 mU/mg for control and 
ZS, respectively. Assays contained 70 cg cell protein. 
Buffers used are as follows: pH 4.5 to 5.0, acetate; pH 
5.4 to 6.4, Mea; pH 7.1 to 9.0, Tris. 
The dependence of the DHAP acyltrans- 
ferase-catalyzed reaction (the acylation of 
DHAP by palmitoyl CoA) on the concen- 
tration of DHAP was examined in both ZS 
and control fibroblasts at pH 5.7. The 
results are presented graphically in Fig. 2 
in the double-reciprocal format. Linear 
regression analysis revealed a biphasic 
pattern in the data for both cell types. Two 
sets of Km and V,, values were apparent, 
one operating at low to moderate DHAP 
concentrations (30-250 PM) and a second 
set which is seen at higher substrate con- 
centrations. Similar results have been re- 
ported for this enzyme from guinea pig 
liver (24,25). The Michaelis constant (Km) 
for DHAP at low concentrations is virtu- 
ally identical for both cell types; the value 
for the ZS fibroblasts is 65 PM DHAP and 
that for the control cells is 68 PM. The I’,,,,, 
values, on the other hand, were dramati- 
cally different. The enzyme in the control 
cell homogenates showed a maximum ve- 
locity of 0.52 mU/mg protein while the ZS 
enzyme gave only 0.03 mU/mg protein. The 
Km and I’,,, values at high DHAP concen- 
trations were 0.33 mM and 0.83 mU/mg for 
the control cells and 0.23 mM and 0.05 
mU/mg for the ZS cells. The graph of rate 
of product formation versus cell protein 
present during assay showed that the ac- 
tivity is linear with up to 100 pg of protein 
in the incubation mixture (Fig. 2, inset). 
There appears to be some variation in 
the levels of enzyme activity from one 
sample of cells to another. For example, in 
control cells the activity of DHAP acyl- 
transferase (at 0.42 mM DHAP) varied 
from 0.21 to 0.35 mU/mg at pH 7.4. This 
may be due to differences in the age of the 
cells lines or the cell population density. In 
a variety of skin fibroblast cultures ob- 
tained from different control patients, the 
DHAP acyltransferase activity was 0.23 
f 0.06 mU/mg (av +- SD; n = 24). Cells from 
confirmed ZS patients have an average en- 
zyme activity of 0.04 + 0.01 mU/mg (n 
= 11). 
The steady-state kinetics of the GP acyl- 
transferase-catalyzed reaction (acylation 
of GP by palmitoyl CoA) in these two cell 
types were also analyzed. These results are 
presented in Fig. 3. The Km value for GP 
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FIG. 2. Effect of increasing DHAP concentration on the rate of acyl DHAP formation by homoge- 
nates of control and ZS fibroblasts. Assay conditions are given in text. Palmitoyl CoA concentration 
is 83 pM. Assay mixtures contained 95 pg cell protein. pH = 5.7; 0 = control; 0 = ZS. Inset shows 
activity vs [protein] at 0.42 mM DHAP. 
was very similar in both the control (0.55 The effects of various treatments on the 
InM) and the ZS (0.51 mM) cells. The enzyme acylation of DHAP and GP in both cell 
showed a higher maximum velocity in the types are compared in Table I. Trypsin- 
ZS cells (3.0 mU/mg protein) as compared treatment produced different effects on 
to the control cells (1.8 mU/mg protein). DHAP acyltransferase activity in control 
The enzyme activity was linear with re- cells (no inhibition) as compared to ZS cells 
spect to protein up to 100 pg (Fig. 3, inset). (76-85s inhibition) at both pH 5.7 and 7.5. 
FIG. 3. Effect of increasing GP concentration on the rate of acyl GP formation by homogenates 
of control and ZS fibroblasts. Assay conditions are given in text. Palmitoyl CoA concentration is 83 
pM. Assay mixtures contained 88 pg cell protein. pH = 7.5; 0 = control; 0 = ZS. Inset shows activity 
vs [protein] at 0.42 mM GP. 
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93 (5.7) - 
40 (7.5) 
DHAPd 
Control - 53 (7.5) 
zs - 53 (7.5) 
Note. Samples of cell homogenate were either 
“treated with trypsin (0.1 mg/mg cell protein) at 37°C 
for 10 min prior to assay; “heated at 45°C for 10 min 
prior to assay; ctreated with 100 pM NEM for 10 min 
prior to assay; or dassayed in the presence of 5 MM 
unlabeled GP or DHAP. Untreated activities were as 
follows: 0.56 and 0.40 mU/mg for DHAP acyltrans- 
ferase in control cells at pH 5.7 and 7.5 respectively; 
0.02 and 0.09 mU/mg for DHAP acyltransferase in 
ZS cells at pH 5.7 and 7.5 respectively. 0.8 and 1.4 
mU/mg for GP acyltransferase in control and ZS cells, 
respectively. 
GP acyltransferase activity, on the other 
hand, was labile towards trypsin in both 
the cell types. Heating samples of cell ho- 
mogenate to 45°C for 10 min destroyed vir- 
tually all of the GP acyltransferase activity 
in both cell types and a large portion of the 
DHAP acyltransferase activity in the ZS 
cells; however, the DHAP acyltransferase 
in the control cell homogenate was actually 
increased by 50-60%. The DHAP acyl- 
transferase activity of ZS cells acting at 
pH 7.5 appears to be more labile to heat 
than is the pH 5.7 activity (Table I). 
NEM has a stimulating effect on the ac- 
ylation of DHAP by homogenates from 
control cells at both pH 5.7 and 7.5. In ZS 
cell homogenates, NEM has an inhibitory 
effect on this reaction; however, its effect 
is much more pronounced at pH 7.5 than 
at pH 5.7. This is similar to the effect of 
heat noted above. GP acyltransferase is 
inhibited by NEM to the same extent (70%) 
in both ZS and control cell homogenates 
(Table I). 
When 5 mM GP is added to the DHAP 
acyltransferase assay mixture it has only 
a small effect on the reaction at pH 5.7 in 
homogenates of both cell types. At pH 7.5, 
a slight inhibition (13%) by GP was ob- 
served for the control cells but quite a sub- 
stantial inhibition was found (60%) in the 
ZS cell homogenate. DHAP, on the other 
hand, strongly inhibits the acylation of GP 
to the same extent (47%)in both cell types. 
The reduction of alkyl DHAP by 
NADPH, catalyzed by acyl/alkyl DHAP 
reductase, was analyzed with respect to its 
dependence on the NADPH concentration. 
The double-reciprocal plots for this enzyme 
are given in Fig. 4. The V,, was essentially 
the same for both cell types with values of 
0.62 and 0.64 mU/mg protein being found 
in the control and ZS lines, respectively. 
The K, for NADPH was also similar for 
both cell lines. The ZS cell line showed a 
value of 5.4 PM while the Km of the control 
line was 5.1 PM. Enzyme activity was linear 
with respect to protein up to 175 pg (Fig. 
4, inset). 
Alkyl DHAP synthase, which forms the 
ether linkage in eukaryotic glycerol-ether 
lipids, was characterized with respect to 
the enzymatic reaction’s dependence on the 
concentration of palmitoyl DHAP. Figure 
5 shows the double-reciprocal plots of the 
resultant data. The enzyme activity in ZS 
and control fibroblasts differed in both Km 
and V,,,. The values for the control cells 
were 17 I.LM and 0.24 mU/mg protein, while 
those for the ZS cells were 30 I.IM and 0.07 
mU/mg protein. Enzyme activity was lin- 
ear with respect to protein up to at least 
90 /*g (Fig. 5, inset). 
When acyl coenzyme A reductase was 
assayed while varying the concentration of 
NADPH (Fig. 6), only a small difference 
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FIG. 4. Effect of increasing NADPH concentration on the rate of acyl DHAP reduction with 
enzyme from control and ZS fibroblasts. Assay conditions are given in text. Palmitoyl DHAP con- 
centration is 0.2 mrd. Assay mixtures contained 45 pg cell protein. 0 = control; 0 = ZS. Inset shows 
activity vs [protein] at 70 &M NADPH. 
was found in the values for V,, (1.18 and 
1.08 nmol/h/mg protein for the control and 
ZS cells, respectively). The control cells 
showed a slightly higher K, for NADPH 
(12.8 PM) as compared to the ZS cells (9.9 
PM). Enzyme activity was linear with re- 
spect to protein up to approximately 100 
pg (Fig. 6, inset). 
Figure 7 compares the sensitivity to the 
thermal inactivation of acyl/alkyl DHAP 
reductase, alkyl DHAP synthase, and acyl 
CoA reductase in both cell types, Both re- 
ductases were substantially inactivated by 
heating to 50°C for 20-30 min whereas al- 
kyl DHAP synthase was only moderately 
affected by this treatment. Surprisingly, 
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FIG. 5. Effect of increasing palmitoyl DHAP concentration on the formation of hexadecyl DHAP 
by homogenates of control and ZS fibroblasts. Assay conditions are given in the text. Hexadecanol 
concentration is 50 @. Assay mixtures contained 73 pg cell protein. 0 = control; 0 = ZS. Inset 
shows activity vs [protein] at ‘75 PM palmitoyl DHAP. 
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FIG. 6. Effect of increasing NADPH concentration on the reduction of palmitoyl CoA to hexadecanol 
with the enzyme from control and ZS fibroblasts. Assay conditions are given in text. Palmitoyl CoA 
concentration is 12.3 FM. Assay mixtures contained 42 pg cell protein. 0 = control; 0 = ZS. Inset 
shows activity vs [protein] at 1.0 my NADPH. 
acyl/alkyl DHAP reductase appears to be 
more stable in the ZS cells than in the con- 
trols. Alkyl DHAP synthase and acyl CoA 
reductase show a greater loss of activity in 
the ZS cell homogenates as compared to 
controls. 
Samples of homogenates of ZS and con- 
trol cells were centrifuged at 170,000~ for 
60 min after which the supernatants and 
pellets were assayed for enzyme activities. 
As expected from the work of others (26, 
27), catalase showed a much higher per- 
centage of activity in the supernatant from 
the ZS cells as compared to that from the 
control cells (90 vs 40%).None of the other 
enzymes showed substantial differences in 
sedimentability between these two cell 
types. The activity in the pellets comprised 
7585% of the total activity for all except 
alkyl DHAP synthase which showed 55% 
in the pellet. 
DISCUSSION 
Although it has previously been estab- 
lished that children born with Zellweger 
syndrome have markedly lower levels of 
plasmalogen in their tissues (13), the cause 
of this deficiency, with respect to enzyme 
activities and kinetic parameters, has not 
been clearly established. Earlier work has 
shown that DHAP acyltransferase activity 
is nearly absent in tissues and cultured skin 
fibroblasts from these patients (7-9) and 
that alkyl DHAP synthase is significantly 
reduced (7,28); however, it was not deter- 
mined whether the defects were manifest 
in the actual numbers of enzyme molecules 
or in the catalytically active structure of 
the enzymes themselves. 
It was found in this work that the DHAP 
acyltransferase activity in normal and ZS 
fibroblasts showed similar Km (DHAP) 
values while I’,,, for this enzyme in the 
ZS cells was decreased by 17-fold. These 
results are interpreted most simply as in- 
dicating that the deficiency of DHAP acyl- 
transferase activity in these cells is due to, 
a lower concentration of active enzyme 
molecules rather than a defect in the 
structure of the protein molecule itself. The 
cause of such a depletion of active enzyme 
is unkown. It may be that in the absence 
of peroxisomes the enzyme is less stable _ 
and more quickly degraded as has been 
demonstrated for acyl CoA oxidase (29) or 
perhaps less enzyme is synthesized when 
its natural destination (the peroxisome) is 
not available. Such a distinction cannot be 
made from these results. Arias et al. (30) 
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FIG. 7. Samples of cell homogenate were heated at 
50°C for the specified lengths of time prior to assay. 
Assay mixtures contained 20-50 pg cell protein. 0 
= control: E4 = ZS. 
reported that the ZS cells used in this study 
have 7-9s of the normal number of per- 
oxisomes found in control fibroblasts. 
Therefore, the level of DHAP acyltrans- 
ferase roughly reflects the level of peroxi- 
somes in these cells. This is not the case 
with catalase which is present at normal 
levels (26). It was considered that DHAP 
acyltransferase in ZS cells may not be 
membrane bound and therefore less cata- 
lytically active. However, when homoge- 
nates of ZS fibroblasts were centrifuged at 
1’70,OOOg for 60 min virtually all of the 
DHAP acyltransferase activity was found 
in the pellet, indicating that the enzyme is 
membrane bound in these cells. It was also 
found that in ZS cell homogenates DHAP 
acyltransferase is labile to trypsin in the 
absence of detergent, whereas in homoge- 
nates of control cells disruption of the 
membranes by detergent is required before 
the enzyme can be inactivated by proteol- 
ysis (Table I). This is strong evidence that 
either the enzyme faces the lumenal side 
of the membrane in normal cells but the 
cytoplasmic side in ZS cells or that this 
membrane-bound enzyme is not vesicular 
in ZS cells. Such a difference in orientation 
may be relevant to the mechanism of in- 
corporation of the enzyme into the peroxi- 
somal membrane (31,32). An alternate ex- 
planation is an increased fragility of the 
few peroxisomes present in the diseased 
cells leading to substantial breakage dur- 
ing cell homogenization. 
In contrast to a previous report from this 
laboratory (‘7), the activity of GP acyl- 
transferase in ZS fibroblasts was found to 
be normal to slightly elevated. This is not 
an unexpected finding since GP acyltrans- 
ferase is known to be localized to the en- 
doplasmic reticulum and mitochondria in 
other cell types and therefore no alteration 
in activity by a depletion of peroxisomes 
should be expected. Although mitochon- 
drial abnormalities are associated with 
this disease, they apparently do not affect 
the activity of GP acyltransferase or, if 
they do, then the effect is compensated by 
the microsomal enzyme pool. This point 
needs to be investigated further. The pre- 
vious finding of lower activity (7) is prob- 
ably due to the fact that trypsin inhibitor 
was not being added before the harvested 
cells were washed. GP acyltransferase is 
especially labile towards trypsin treat- 
ment; however, addition of trypsin inhib- 
itor was found to have a protective effect 
on nearly all the enzymes we routinely as- 
sayed. 
The increase in I’,,, for GP acyltrans- 
ferase found in the ZS cells may be phys- 
iologically necessary to balance the loss of 
DHAP acyltransferase activity since both 
of these enzymes are involved in the syn- 
thesis of lysophosphatidate. It is also 
known that fibroblasts from ZS patients 
substitute diacyl glycerolipids on a nearly 
equivalent basis for the missing alkyl/acyl 
and alkenyl/acyl glycerolipids (33,34). 
The NEM-induced increase in DHAP 
acyltransferase activity in the control cell 
homogenates is probably due to inhibition 
of competing enzymes (e.g., acyl CoA hy- 
drolase, GP acyltransferase, etc.) or pos- 
sibly could be due to removal of the prod- 
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uct, coenzyme A. This stimulation of 
DHAP acyltransferase by NEM has also 
been observed in liver (24). 
The properties of DHAP acyltransferase 
in ZS are quite different than the corre- 
sponding enzyme in the normal cells. For 
example, ZS DHAP acyltranferase is more 
labile towards trypsin and heat and more 
inhibited by NEM than the control. In this 
respect the ZS DHAP acyltransferase is 
similar to GP acyltransferase which raises 
an interesting question, i.e., whether or not 
the residual activity of DHAP acyltrans- 
ferase in ZS is due to the nonspecificity of 
GP acyltransferase. Microsomal GP acyl- 
transferase has been postulated to have 
dual catalytic activity (35). Though it is not 
evident with the normal cells, it is possible 
that GP acyltransferase catalyzes the ac- 
ylation of DHAP at 4% the rate of GP ac- 
ylation so that it becomes apparent only 
when 95% of the masking DHAP acyl- 
transferase is absent. On the other hand, 
at pH 5.7 (where GP acyltransferase is in- 
active) DHAP acyltransferase in ZS cells 
(but not in normal controls) is labile to- 
wards trypsin and heat, indicating that in 
ZS cells residual DHAP acyltransferase is 
present but its properties are different than 
in normal cells. Nevertheless, assuming 
that the DHAP acyltransferase in ZS has 
the same pH activity profile as the normal 
control it could be calculated that 80% of 
the pH 7.5 DHAP acyltransferase activity 
is due to GP acyltransferase. Further 
evidence for this interpretation is that 
unlabeled GP added to the DHAP acyl- 
transferase assay at 12 times the DHAP 
concentration inhibited DHAP acyltrans- 
ferase activity by 60% at pH 7.5 (Table I) 
in the ZS cells. From these results it can 
be concluded that the rate of acylation of 
DHAP by GP acyltransferase is negligible 
(2-4% ) compared to the DHAP acyltrans- 
ferase activity in normal controls. Residual 
DHAP acyltransferase activity in ZS cells 
is only 2-3% of normal cells. 
Acyl/alkyl DHAP reductase shows no 
significant difference in activity between 
control and ZS fibroblasts. Therefore, the 
activity of this enzyme is presumably not 
a contributing factor to the low levels of 
ether lipids characteristic of this disease. 
On the other hand, alkyl DHAP synthase 
has abnormal kinetic constants in the ZS 
cells. The V,,,, for alkyl DHAP synthase 
in these cells is only 30% of the normal 
value and the Km value for acyl DHAP is 
approximately doubled (1’7 vs 30 PM). A 70% 
decrease in activity was reported previ- 
ously (7); however; those results did not re- 
flect the maximum velocity of the enzyme. 
Schrakamp et aZ. (28) have reported a Km 
value for palmitoyl DHAP of 30 pM and a 
V,,, of 0.13 mU/mg in cultured normal 
skin fibroblasts. Their finding of lower ac- 
tivity than reported here may be due to 
residual trypsin from the harvesting pro- 
cedure as mentioned above. We have found 
reduced enzyme activities when the tryp- 
sinization was not stopped with trypsin in- 
hibitor. 
Although it is not possible to say with 
certainty what is occurring in the living 
cell, these results would indicate that alkyl 
DHAP synthase activity is not rate limit- 
ing in the formation of alkyl DHAP in ZS 
fibroblasts since the absolute activity of 
DHAP acyltransferase is lower than that 
of alkyl DHAP synthase. However, the ac- 
tual catalytic rates of these enzymes in the 
cell will depend not only on their substrate 
concentrations in the vicinity of each en- 
zyme but very possibly on other factors as 
well (e.g., allosteric effects, subcellular lo- 
cation, etc.). 
Acyl coenzyme A reductase, which pro- 
duces the long-chain alcohols required for 
glycerol ether lipid synthesis, was found to 
have a normal V,,, in the ZS fibroblasts. 
Although this is not an unexpected result, 
since little is known of the subcellular dis- 
tribution of this enzyme, it is an indication 
that either this enzyme is not normally 
resident in human fibroblast peroxisomes 
or else its level is not changed by the in- 
ability to become incorporated into these 
organelles. It is worth mentioning, how- 
ever, that Bishop and Hajra (21) found 
preliminary evidence that acyl CoA reduc- 
tase may be present in rat brain micro- 
peroxisomes. 
In summary, we have found that, of the 
four acyl DHAP pathway enzymes and GP 
acyltransferase, only DHAP acyltransfer- 
ase and alkyl DHAP synthase are deficient 
620 WEBBER, DATTA, AND HAJRA 
in skin fibroblasts from ZS patients. The 15. 
defect in the biosynthesis of glycerol ether 
lipids, characteristic of Zellweger syn- 16. 
drome, appears to be attributable to the 17. 
near absence of DHAP acyltransferase ac- 
tivity although the lower level of alkyl 1s. 
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